ESG

At Agrishow 2026, EAVISION's new J150 drone showcases advanced AI and terrain-following tech to tackle Brazil's unique agricultural challenges.

The top organic bread brand launches mini bagels to meet consumer demand for smaller portions, a strategic move backed by its powerful social mission.

As it preps a first-in-human study for a deadly genetic heart disease, Nuevocor brings on gene therapy veteran Dr. Monica Shah to lead the charge.

Ascidian Therapeutics to present first human safety data for its Stargardt disease drug, a new RNA editing technology with broad potential for genetic diseases.

At IFAT 2026, Scania presents a versatile portfolio for cities, blending electrification, biofuels, and top-tier safety to navigate the urban future.

A new trade event in Kuala Lumpur signals China's shift from simple exports to a strategy of two-way investment and digital-physical market dominance.

With gonorrhea becoming increasingly resistant to antibiotics, a new $2.6M grant fuels the development of a promising preventative vaccine platform.

Bhutan announces its first International Travel Mart, a bold move to attract elite partners and showcase the visionary Gelephu Mindfulness City.

Amity University's international workshop leverages AI and global expertise to forge a new path for digital accessibility in India's higher education.

The Chinese AI credit platform's latest ESG report signals a growing focus on sustainability and social impact amid tightening market and regulatory pressures.

A Shenzhen tech firm's portable monitor is a bestseller in Japan, shaking up mobile gaming with its dock-free Switch connectivity and versatile design.

Backed by activist investor Irenic Capital, a new $220M blank-check firm hits Nasdaq, aiming to acquire a target in the aerospace or industrial sectors.

Brazil's new antimicrobial rules are shaking up the livestock industry. See how Phibro is pivoting from growth promotion to a digital, therapeutic future.

Biotech firm Tr1X unveils promising data for its novel cell therapies, offering a scalable new approach to treating autoimmune diseases like MS and GvHD.

Dyno Therapeutics is using AI to design 'smart' viral vectors, promising safer, more effective treatments for untreatable genetic diseases.

Set to unveil its "best of both" PRINT™ platform, Addition Therapeutics aims to cure diseases from Fabry to HIV with a single, durable genetic medicine.

After a major transformation, agilon health appoints a new CEO with deep payor and provider expertise to scale its value-based care model for seniors.

Cambridge biotech to unveil AI-powered LNP platform at ASGCT 2026, targeting fat and T-cells to unlock new treatments for obesity and cancer.

Umoja Biopharma's UB-VV500 aims to revolutionize myeloma care by creating a dual-antigen CAR T therapy directly inside the patient's body.

Nathalie Vranken takes the helm as Chairwoman and CEO at Maison Pommery, but a looming debt deadline and refinancing delay overshadow record performance.